294 related articles for article (PubMed ID: 24801745)
1. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.
Panicker LM; Miller D; Awad O; Bose V; Lun Y; Park TS; Zambidis ET; Sgambato JA; Feldman RA
Stem Cells; 2014 Sep; 32(9):2338-49. PubMed ID: 24801745
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease.
Panicker LM; Miller D; Park TS; Patel B; Azevedo JL; Awad O; Masood MA; Veenstra TD; Goldin E; Stubblefield BK; Tayebi N; Polumuri SK; Vogel SN; Sidransky E; Zambidis ET; Feldman RA
Proc Natl Acad Sci U S A; 2012 Oct; 109(44):18054-9. PubMed ID: 23071332
[TBL] [Abstract][Full Text] [Related]
3. C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages.
Serfecz JC; Saadin A; Santiago CP; Zhang Y; Bentzen SM; Vogel SN; Feldman RA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576075
[TBL] [Abstract][Full Text] [Related]
4. Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.
Sgambato JA; Park TS; Miller D; Panicker LM; Sidransky E; Lun Y; Awad O; Bentzen SM; Zambidis ET; Feldman RA
Stem Cells Transl Med; 2015 Aug; 4(8):878-86. PubMed ID: 26062980
[TBL] [Abstract][Full Text] [Related]
5. Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition.
Panicker LM; Srikanth MP; Castro-Gomes T; Miller D; Andrews NW; Feldman RA
Hum Mol Genet; 2018 Mar; 27(5):811-822. PubMed ID: 29301038
[TBL] [Abstract][Full Text] [Related]
6. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
[TBL] [Abstract][Full Text] [Related]
8. Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism.
Kopytova AE; Rychkov GN; Nikolaev MA; Baydakova GV; Cheblokov AA; Senkevich KA; Bogdanova DA; Bolshakova OI; Miliukhina IV; Bezrukikh VA; Salogub GN; Sarantseva SV; Usenko TC; Zakharova EY; Emelyanov AK; Pchelina SN
Parkinsonism Relat Disord; 2021 Mar; 84():112-121. PubMed ID: 33609962
[TBL] [Abstract][Full Text] [Related]
9. Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease.
Srikanth MP; Feldman RA
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287247
[TBL] [Abstract][Full Text] [Related]
10. CRISPR Correction of the GBA Mutation in Human-Induced Pluripotent Stem Cells Restores Normal Function to Gaucher Macrophages and Increases Their Susceptibility to Mycobacterium tuberculosis.
Ramalingam S; Kumar A; Krug S; Mohan H; Rao DN; Bishai WR; Chandrasegaran S
J Infect Dis; 2023 Sep; 228(6):777-782. PubMed ID: 37159513
[TBL] [Abstract][Full Text] [Related]
11. iPSC-Derived Gaucher Macrophages Display Growth Impairment and Activation of Inflammation-Related Cell Death.
Messelodi D; Bertuccio SN; Indio V; Strocchi S; Taddia A; Serravalle S; Bandini J; Astolfi A; Pession A
Cells; 2021 Oct; 10(11):. PubMed ID: 34831047
[TBL] [Abstract][Full Text] [Related]
12. Generation of two iPSC lines derived from two unrelated patients with Gaucher disease.
Nagel M; Reichbauer J; Böhringer J; Schelling Y; Krägeloh-Mann I; Schüle R; Ulmer U
Stem Cell Res; 2019 Mar; 35():101336. PubMed ID: 30606667
[TBL] [Abstract][Full Text] [Related]
13. The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease.
Ivanova MM; Dao J; Loynab N; Noor S; Kasaci N; Friedman A; Goker-Alpan O
Cells; 2024 Apr; 13(8):. PubMed ID: 38667330
[TBL] [Abstract][Full Text] [Related]
14. Induced Pluripotent Stem Cell Modeling of Gaucher's Disease: What Have We Learned?
Santos DM; Tiscornia G
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28430167
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology.
Mucci JM; Cuello MF; Kisinovsky I; Larroude M; Delpino MV; Rozenfeld PA
Blood Cells Mol Dis; 2015 Aug; 55(2):134-43. PubMed ID: 26142329
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene.
Duarte AJ; Ribeiro D; Santos R; Moreira L; Bragança J; Amaral O
Stem Cell Res; 2019 Dec; 41():101595. PubMed ID: 31678773
[TBL] [Abstract][Full Text] [Related]
17. Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs.
Aflaki E; Stubblefield BK; Maniwang E; Lopez G; Moaven N; Goldin E; Marugan J; Patnaik S; Dutra A; Southall N; Zheng W; Tayebi N; Sidransky E
Sci Transl Med; 2014 Jun; 6(240):240ra73. PubMed ID: 24920659
[TBL] [Abstract][Full Text] [Related]
18. Altered Differentiation Potential of Gaucher's Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation.
Awad O; Panicker LM; Deranieh RM; Srikanth MP; Brown RA; Voit A; Peesay T; Park TS; Zambidis ET; Feldman RA
Stem Cell Reports; 2017 Dec; 9(6):1853-1867. PubMed ID: 29198828
[TBL] [Abstract][Full Text] [Related]
19. Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells.
Awad O; Sarkar C; Panicker LM; Miller D; Zeng X; Sgambato JA; Lipinski MM; Feldman RA
Hum Mol Genet; 2015 Oct; 24(20):5775-88. PubMed ID: 26220978
[TBL] [Abstract][Full Text] [Related]
20. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.
Bondar C; Ormazabal M; Crivaro A; Ferreyra-Compagnucci M; Delpino MV; Rozenfeld PA; Mucci JM
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
